1. Yan, Hai, Parsons, D Williams, Jin, Genglin, Vogelstein, Bert, Bigner, Darell D. . IDH1 and IDH2 mutations in gliomas. In The New England journal of medicine, 360, 765-73. doi:10.1056/NEJMoa0808710. https://pubmed.ncbi.nlm.nih.gov/19228619/
2. Kim, Jee In, Noh, Mi Ra, Yoon, Ga-Eun, Kong, Min Jung, Park, Kwon Moo. . IDH2 gene deficiency accelerates unilateral ureteral obstruction-induced kidney inflammation through oxidative stress and activation of macrophages. In The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, 25, 139-146. doi:10.4196/kjpp.2021.25.2.139. https://pubmed.ncbi.nlm.nih.gov/33602884/
3. Zhao, Yan-Xia, Shen, Xu-Liang. . [Research Advances of IDH2 Gene Mutation in Acute Myeloid Leukemia]. In Zhongguo shi yan xue ye xue za zhi, 24, 632-6. doi:10.7534/j.issn.1009-2137.2016.02.061. https://pubmed.ncbi.nlm.nih.gov/27151043/
4. Figueroa, Maria E, Abdel-Wahab, Omar, Lu, Chao, Levine, Ross L, Melnick, Ari. 2010. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. In Cancer cell, 18, 553-67. doi:10.1016/j.ccr.2010.11.015. https://pubmed.ncbi.nlm.nih.gov/21130701/